Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
other · US Department of Health and Human Services · Rule · Published 2026-03-13 · 91 FR 12308
Document
Document number
2026-04981
Federal Register citation
91 FR 12308
Type
Rule
Action
Issuance of authorized drug testing panels.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
2026-03-13
Abstract
HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025.